Desktop
Tablet
Mobile

FLEXBUMIN® 5% AND FLEXBUMIN 25%

TRUSTED BY HOSPITALS FOR OVER 19 YEARS1-3*

FLEXBUMIN IS THE FIRST HUMAN ALBUMIN IN A FLEXIBLE, SHATTERPROOF CONTAINER.1-4*

LEARN MORE ABOUT FLEXBUMIN

*FLEXBUMIN 25% Solution was FDA approved on October 11, 2005.3

https://main--flexbumin--onetakeda.aem.page/fragments/indication-banner

THE FLEXBUMIN CONTAINER

LEARN MORE

FLEXBUMIN IV SOLUTION

LEARN MORE

style
center

ABOUT ALBUMIN

Human albumin solutions have been studied extensively and used therapeutically for more than 80 years in the US.5-7

MORE ABOUT ALBUMIN

style
Contained, Cozy, Center, Secondary Subtle, lead text , about albumin section

GET ANSWERS TO YOUR QUESTIONS.

Takeda has a dedicated and experienced hospital team of account managers who can provide a personal and tailored approach to address the needs of your system.

CONTACT A REPRESENTATIVE

style
Lead Gen, Center, Content Width XL
background
References
  1. FLEXBUMIN 25% [Albumin (Human)], USP, 25% Solution. Prescribing information. Takeda Pharmaceuticals U.S.A., Inc.; 2024.
  2. FLEXBUMIN 5% [Albumin (Human)], USP, 5% Solution. Prescribing information. Takeda Pharmaceuticals U.S.A., Inc.; 2024.
  3. Data on file. VV-MED-7455—FLEX-013 FLEXBUMIN biologics license application.
  4. Data on file. FLEXBUMIN 25% biological license application.
  5. Bertolini J, Goss N, Curling J, eds. Production of Plasma Proteins for Therapeutic Use. Hoboken, NJ: John Wiley & Sons; 2013.
  6. Center for Biologic Evaluation and Research. List of licensed biological products with reference product exclusivity and biosimilarity or interchangeability evaluations to date. Accessed March 3, 2025. Available at: https://www.fda.gov/media/105605/download
  7. Marketing Research Bureau. The Plasma Proteins Market in the United States 2019. July 2020.
style
References, Flush, Content Width LG